Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

21. Octobre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2861


	Articles 1 - 20 / 57214

	Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices. Cancer Metastasis Rev Zhang YF, Gan W, Wang WQ, Liu L. PMID: 41117977 [PubMed - indexed for MEDLINE]
	Adjuvant treatment after surgical resection of pancreatic cancer. Surg Today Tomimaru Y, Eguchi H. PMID: 41117833 [PubMed - as supplied by publisher]
	Meta-Analysis: Immune-Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Aliment Pharmacol Ther Liu S, Li Z, Lin J, Ke L, Hua Y. PMID: 41116751 [PubMed - as supplied by publisher]
	Circadian genes CLOCK and BMAL1 in cancer: mechanistic insights and therapeutic strategies. J Zhejiang Univ Sci B Shen Y, Zhao Y, Sun X, Ji G, Xu D, Wang Z. PMID: 41116204 [PubMed - indexed for MEDLINE]
	Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial. Nat Med Tie J, Wang Y, Loree JM, Cohen JD, Wong R, Price T, Tebbutt NC, Gebski V, Espinoza D, Burge M, Harris S, Lynam J, Lee B, Lee MM, Breadner D, Debrincat M, Foroughi S, Chantrill L, Lim SH, Gill S, O'Callaghan C, Ptak J, Silliman N, Dobbyn L, Popoli M, Bettegowda C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P, AGITG DYNAMIC-III Study Group (Intergroup Study of the Australasian Gastro-Intestinal Trials Group and Canadian Cancer Trials Group). PMID: 41115959 [PubMed - as supplied by publisher]
	Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection. Front Oncol Zhang JX, Guo LB, Zeng CS, Huang QZ, Lai ZS, Wu MM, Chen QJ, Lai YP, Qiu XF, Zhang B, Zhang JC, Lv JH, Huang LM, You WY, Wang B, Lin KY, Kow AWC, Zeng YY. PMID: 41114363 [PubMed]
	Tumor microenvironment phenotyping guides precision therapy in unresectable pancreatic cancer. World J Gastrointest Oncol Zhao K, Xiao MM, Yang YS, Xiao X. PMID: 41114111 [PubMed]
	Current insights and future perspectives of treatment strategies for biliary tract cancer. World J Gastrointest Oncol Nakagawa K, Tsujinaka S, Katayose Y, Yambe K, Sakurai H, Takami K, Kondo N, Yamamoto K, Shibata C. PMID: 41114096 [PubMed]
	Incorporating nivolumab with preceded gemcitabine and S-1 chemotherapy for patients of metastatic pancreatic cancer: a pilot study. Am J Cancer Res Yang SH, Chen BB, Lee JC, Kuo YT, Kuo SH, Cheng AL, Yeh KH. PMID: 41113977 [PubMed]
	Early detection of pancreatic cancer on computed tomography: advancements with deep learning. Radiol Adv Lopez-Ramirez F, Syailendra EA, Tixier F, Kawamoto S, Fishman EK, Chu LC. PMID: 41113902 [PubMed]
	Association between antidiabetic drugs and cancer risk in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. World J Diabetes An XD, Duan LY, Zhang YH, Jia QY, Zhang YM, Qiao Y. PMID: 41113488 [PubMed]
	Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer. Front Immunol Wu M, Li G, Li Y, Chen K, Xu M, Li D, Xu C, Shen M, Li W, Cao J. PMID: 41112307 [PubMed - indexed for MEDLINE]
	Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study). Int J Clin Oncol Terashima T, Morizane C, Chida A, Todaka A, Umemoto K, Kawakami Y, Yamashita T, Ueno M, Furuse J, Nagano H. PMID: 41110012 [PubMed - as supplied by publisher]
	Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM project. BMC Cancer Hillen B, Oestreicher G, Schwab L, Enders K, Simon P, Elme A, Ben-Aharon I, Goshenlago T, Neuzillet C, Sclafani F, Beltran EEM, Schuster M, Doncheva H, Ruckes C, Karlecik M, Petrowski K, Rosenbaum D, Diou C, Ballas A, Vlachostergiou A, Mastricci D, Scherrer A, Pilz M, Flechsig J, Apostolidis L, Krooupa AM, Chintha S, Musisi IW, Tzavara NP, Kakasis A, Hadjikypri X, Karra S, Chatzipanagiotou K, Drivas I, Dacasa H, Moehler M. PMID: 41109944 [PubMed - indexed for MEDLINE]
	Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. J Transl Med Zhang Q, Cao Z, Yan S, Chen B, Wu H, Cao H, Lin C, Liu Z. PMID: 41107877 [PubMed - indexed for MEDLINE]
	Diagnostic valuation of MMP family members as biomarkers for pancreatic cancer: a systematic review and meta-analysis. Biomark Med Lu M, Jiang D, Zhang J, Liu L, Shen Y, Li T, Wang P, Shi J, Wang K, Ye H. PMID: 41105435 [PubMed - in process]
	Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes. JAMA Netw Open Stefanova I, Thompson N, Oldfield L, Stott M, Hanson R, Palmer D, Halloran C, Greenhalf W, Van Der Meer R, Costello E. PMID: 41105406 [PubMed - indexed for MEDLINE]
	Characterizing and Addressing the Financial, Time, and Administrative Burdens of Cancer and its Care. Curr Treat Options Oncol Lin K, Kagalwalla S, Gupta A. PMID: 41105191 [PubMed - as supplied by publisher]
	Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients. Hepatobiliary Surg Nutr Cheung KS, Wan EYF, Zhou J, Lam CLK, Leung WK. PMID: 41104217 [PubMed]
	Neoadjuvant systemic therapy for hepatocellular carcinoma: challenges and opportunities-a narrative review. Hepatobiliary Surg Nutr Zhang Y, Yue S, Zhang B, Chen X, Zhang W. PMID: 41104208 [PubMed]

Articles 1 - 20 / 57214

Page 1 de 2861



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité